Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research interests include Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Sarcoma Diagnosis and Treatment, and RNA modifications and cancer.
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
<i>NTRK</i> fusions in osteosarcoma are rare and non‐functional events
Overactivation of the <scp>IGF</scp> signalling pathway in osteosarcoma: a potential therapeutic target?
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib
The evolutionary landscape of colorectal tumorigenesis
Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas